Sunday - November 15, 2026
Sidley Represents Hanmi Pharm and Green Cross Biopharma in Licensing Agreement With BioMarin
October 30, 2026
CHICAGO, Illinois, Oct. 30 [Category: BizLaw/Legal] -- Sidley Austin, a law firm, posted the following news release:

* * *

Sidley Represents Hanmi Pharm and Green Cross Biopharma in Licensing Agreement With BioMarin

*

Sidley represented GC Biopharma Corp. and Hanmi Pharm Co., Ltd. in an exclusive licensing agreement with BioMarin Pharmaceutical Inc. for LA-GLA (HM15421/GC1134A), a jointly developed next-generation therapy for Fabry disease. The . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products